Clinical Trial Update: Lactoferrin for Prevention of Sepsis in Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lactoferrin for prevention of late-onset neonatal sepsis in infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Neonatal Sepsis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Universidad Peruana Cayetano Heredia | Conditions: Late Onset Neonatal Sepsis | Phase 3 | Status: COMPLETED